LENSAR Halts Alcon Merger, Secures $10 Million Deposit After FTC Challenge
LENSAR and Alcon terminated their merger agreement after the FTC signaled it would block the acquisition, leaving regulatory approval unmet by the April 23, 2026 deadline. The company will retain the $10 million deposit and report 2025 fourth-quarter and full-year results with strategic updates on March 31, 2026.
1. Merger Termination
LENSAR and Alcon mutually agreed to terminate their merger agreement after the Federal Trade Commission indicated intent to enjoin the deal, as the required regulatory approval was unlikely by the April 23, 2026 outside date or the potential July 23 extension.
2. Financial Implications
With the termination, LENSAR retains the $10.0 million deposit from Alcon, though management notes potential costs, expenses and fees associated with unwinding the transaction and possible litigation risks.
3. Forward Strategy
The company remains focused on expanding its ALLY Robotic Cataract Laser System™ installed base and procedure volumes, aiming to capture untapped market opportunities and will outline detailed strategy alongside fourth-quarter and full-year 2025 results on March 31, 2026.